NCT06415487: ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) |
|
|
| Not yet recruiting | 1 | 30 | US | Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab | Acepodia Biotech, Inc. | Locally Advanced Solid Tumor, Metastatic Solid Tumor | 12/26 | 03/27 | | |
